Back
RAPT Therapeutics 10K Form
Buy
52
RAPT
RAPT Therapeutics
Last Price:
$1.59
Seasonality Move:
-30.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RAPT News And Ratings
See the #1 stock for the next 7 days that we like better than RAPT
RAPT Financial Statistics
Sales & Book Value
| Annual Sales: | $1.5M |
|---|---|
| Cash Flow: | $-17.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.74 |
| Price / Book: | 0.59 |
Profitability
| EPS (TTM): | -2.78000 |
|---|---|
| Net Income (TTM): | $-107.5M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
RAPT Therapeutics Earnings Forecast
Key RAPT Therapeutics Financial Ratios
-
Per Share Earnings over the last 7 years have been positive in 1 years.
RAPT Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RAPT |
| CUSIP: | 75382E |
| Website: | rapt.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RAPT Technical Analysis vs Fundamental Analysis
Buy
52
RAPT Therapeutics (RAPT)
is a Buy
Is RAPT Therapeutics a Buy or a Sell?
-
RAPT Therapeutics stock is rated a BuyThe current RAPT Therapeutics [RAPT] share price is $1.62. The Score for RAPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.